NHS England to fund Actelion's Uptravi - PharmaTimes

NHS England to fund Actelion's Uptravi  PharmaTimes

Actelion has announced that NHS patients in England, who have the rare, incurable and devastating disease pulmonary arterial hypertension (PAH) can now be ...



Comments

Popular posts from this blog

4 Symptoms of Stress You Should Never Ignore - AARP

What is lung scraping for COPD, and who may need it? - Medical News Today

Dyspnea (Shortness of Breath): Causes, Symptoms & Treatment - my.clevelandclinic.org